-
Product Insights
ORA – Revesby Beverage Can Manufacturing Plant Expansion – New South Wales
Equip yourself with the essential tools needed to make informed and profitable decisions with our ORA – Revesby Beverage Can Manufacturing Plant Expansion – New South Wales report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CAN-1012 SR in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CAN-1012 SR in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CAN-1012 SR in Solid Tumor Drug Details: CAN-1012 is under...
-
Thematic Analysis
NewBlockchain in Automotive – Thematic Intelligence
Blockchain is a type of distributed ledger comprised of unchangeable, digitally recorded data in packages called blocks. Each block is “chained” to the next block using a cryptographic signature. The technology can be viewed as a digital record of transactions that is decentralized, meaning no central authority, such as government or bank, validates a transaction. The initial development of blockchain generated huge interest, with companies adopting the technology for novelty rather than strategic reasons. Since then, more practical, efficiency-based use...
-
Track & Monitor
Cybersecurity in automotive: Vehicle CAN security
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Vehicle CAN security segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Analyst Opinions
NewBroker Distribution Insight 2024 – Which Insurers Lead the Way?
This report explores which insurers can be considered market leaders from the point of view of commercial brokers. The report looks at factors that brokers find most important when selecting an insurer with which to place business, analyzing how this has changed over the course of the cost-of-living crisis. Across 11 different aspects questioned, brokers select the insurer they consider to be best in class. The four leading insurers are discussed individually, as well as each separate category. The top...
-
Company Insights
NewSamsung Pay – Competitor Profile
Samsung Pay is a mobile payment solution launched by Samsung in August 2015. Samsung Pay is available for a range of Samsung products, including its Galaxy devices and Gear wearable technology. It was the first mobile payment offering to support NFC, magnetic secure transmission, and barcode scanning in a single solution. It is supported by more than 2,800 international and regional banks and credit unions in the US, including Bank of America, Wells Fargo, Citibank, Capital One, PNC, and TD...
-
Product Insights
NewNet Present Value Model: Sanofi’s INBRX-101
Empower your strategies with our Net Present Value Model: Sanofi's INBRX-101 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence. emphysema. The therapeutic candidate comprises of alpha-1 antitrypsin (AAT)-Fc fusion proteins and developed based...
-
Product Insights
NewNet Present Value Model: Inhibrx Inc’s INBRX-101
Empower your strategies with our Net Present Value Model: Inhibrx Inc's INBRX-101 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence. emphysema. The therapeutic candidate comprises of alpha-1 antitrypsin (AAT)-Fc fusion proteins and developed...
-
Track & Monitor
NewInnovation in defence: Aerial refueling
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the defence industry’s Aerial refueling segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewInnovation in Retail: Self-checkout
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the retail industry’s Self-checkout segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.